EGF Theramed Health Corp. (CSE:TMED.X)
0.0400
0.00 (0.00%)
At close: Nov 17, 2026
EGF Theramed Health Balance Sheet
Financials in millions CAD. Fiscal year is July - June.
Millions CAD. Fiscal year is Jul - Jun.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash & Equivalents | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 |
Short-Term Investments | 0 | 0 | 0 | 0 | 0 |
Cash & Short-Term Investments | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 |
Cash Growth | 6.14% | 39.96% | -14.58% | -23.06% | -97.83% |
Other Receivables | - | - | 0.2 | 0.17 | 0.15 |
Receivables | - | - | 0.2 | 0.17 | 0.15 |
Prepaid Expenses | 0 | 0.01 | 0 | 0.01 | 0.01 |
Total Current Assets | 0.02 | 0.02 | 0.21 | 0.19 | 0.18 |
Other Long-Term Assets | 0 | 0 | 0 | 0 | 0 |
Total Assets | 0.02 | 0.02 | 0.21 | 0.19 | 0.18 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Accounts Payable | 2.01 | 1.32 | 1.33 | 1.26 | 0.99 |
Accrued Expenses | - | - | 0.01 | - | - |
Short-Term Debt | 1.12 | 0.99 | 1 | 0.92 | 0.84 |
Current Portion of Long-Term Debt | 0 | 0 | 0 | 0 | - |
Current Portion of Leases | 0.59 | 0.52 | 0.47 | 0.42 | 0.38 |
Current Income Taxes Payable | 3.14 | 2.94 | - | - | - |
Other Current Liabilities | 0.02 | 0.16 | 0.1 | 0.07 | 0.3 |
Total Current Liabilities | 6.89 | 5.93 | 2.92 | 2.67 | 2.51 |
Long-Term Debt | - | - | - | - | 0 |
Total Liabilities | 6.89 | 5.93 | 2.92 | 2.67 | 2.51 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Common Stock | 50.6 | 50.6 | 50.58 | 50.48 | 50.21 |
Additional Paid-In Capital | 4.13 | 4.13 | 4.13 | 4.16 | 3.93 |
Retained Earnings | -60.2 | -59.28 | -56.08 | -55.81 | -55.18 |
Comprehensive Income & Other | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 |
Total Common Equity | -5.45 | -4.52 | -1.34 | -1.14 | -1.02 |
Minority Interest | -1.42 | -1.39 | -1.36 | -1.34 | -1.32 |
Shareholders' Equity | -6.87 | -5.91 | -2.7 | -2.48 | -2.34 |
Total Liabilities & Equity | 0.02 | 0.02 | 0.21 | 0.19 | 0.18 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Total Debt | 1.72 | 1.51 | 1.47 | 1.34 | 1.22 |
Net Cash (Debt) | -1.71 | -1.5 | -1.46 | -1.33 | -1.2 |
Net Cash Growth | - | - | - | - | - |
Net Cash Per Share | -0.15 | -0.13 | -0.13 | -0.13 | -0.56 |
Filing Date Shares Outstanding | 11.62 | 11.62 | 11.62 | 11.39 | 2.16 |
Total Common Shares Outstanding | 11.62 | 11.62 | 11.39 | 10.49 | 2.16 |
Working Capital | -6.87 | -5.91 | -2.71 | -2.48 | -2.34 |
Book Value Per Share | -0.47 | -0.39 | -0.12 | -0.11 | -0.47 |
Tangible Book Value | -5.45 | -4.52 | -1.34 | -1.14 | -1.02 |
Tangible Book Value Per Share | -0.47 | -0.39 | -0.12 | -0.11 | -0.47 |